Cellular Dynamics International Inc (ICEL) is one of today’s most notable gainers, up 107% to $16.47 on 1.1 million shares. The spike comes after Japan’s Fujifilm Holdings Corp announced its agreement to acquire the U.S.-based biotechnology firm for $307 million.
Under the terms of the deal, which were approved by both companies’ boards, Fujifilm will make a tender offer for all of Cellur Dynamics for $16.50 per share. The offer represents a premium of 108% to CDI’s closing pps on the Nasdaq on Friday.
Fundamentally, ICEL shows the following financial data:
- $34.41 million in cash in most recent quarter
- $58.83 million t-12 total assets
- $37.82 million total equity
- $16.69 million t-12 revenue
- ($30.6) million annual net income
On valuation measures, Cellular Dynamics International Inc. shares have a T-12 price/sales ratio of 7.52 and a price/book for the same period of 3.32. EPS is ($1.94). The name has a market cap of $260.61 million and a median Wall Street price target of $13.00 with a high target of $15.00. Currently there are 3 analysts that rate ICEL a ‘Buy’. No analyst rates a ‘Hold’ or a ‘Sell’.
In terms of share statistics, Cellular Dynamics International Inc. has a total of 15.81 million shares outstanding with 43.98% held by insiders and 39.70% held by institutions. The stock’s short interest currently stands at 3.54%, bringing the total number of shares sold short to 480,328.